Advertisement

Cultural and Socioeconomic Determinants of Antibiotic Use

  • Stephan Harbarth
  • Dominique L. Monnet

Abstract

Widespread antimicrobial resistance among bacterial pathogens has compromised traditional therapy with narrow-spectrum antibiotics and may result in adverse outcomes. Although no region in the world has been excluded from the inexorable spread of increasingly resistant bacteria, large disparities in the global epidemiology of antibiotic resistance can be observed.1 The reasons for the uneven geographic distribution of antibiotic-resistant microorganisms are not fully understood. A variety of factors are responsible for this, but the selective pressure exerted by inappropriately used antibiotics is likely the most important. Antibiotic use may differ between and within countries. For example, in 2002, antibiotic consumption was three times higher in France than in the Netherlands, with other European countries reporting a wide range of antibiotic consumption rates between these extreme values.

Keywords

Power Distance Uncertainty Avoidance Antibiotic Consumption Emerg Infect Socioeconomic Determinant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tiemersma EW, Bronzwaer SL, Lyytikainen O, et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002. Emerg Infect Dis 2004;10:1627–34.PubMedGoogle Scholar
  2. 2.
    Baquero F, Baquero-Artigao G, Canton R, Garcia-Rey C. Antibiotic consumption and resistance selection in Streptococcus pneumoniae. J Antimicrob Chemother 2002;50 Suppl S2:27–37.Google Scholar
  3. 3.
    Albrich WC, Monnet DL, Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis 2004;10:514–7.PubMedGoogle Scholar
  4. 4.
    Bjerrum L, Boada A, Cots JM, et al. Respiratory tract infections in general practice: Considerable differences in prescribing habits between general practitioners in Denmark and Spain. Eur J Clin Pharmacol 2004;60:23–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet 2005;365:579–87.PubMedGoogle Scholar
  6. 6.
    Avorn J, Solomon DH. Cultural and economic factors that (mis)shape antibiotic use: the nonpharmacologic basis of therapeutics. Ann Intern Med 2000;133:128–35.PubMedGoogle Scholar
  7. 7.
    Harbarth S, Albrich W, Goldmann DA, Huebner J. Control of multiply resistant cocci: Do international comparisons help? Lancet Infect Dis 2001;1:251–61.CrossRefPubMedGoogle Scholar
  8. 8.
    Harbarth S, Albrich W, Brun-Buisson C. Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: A sociocultural perspective. Emerg Infect Dis 2002;8:1460–7.PubMedGoogle Scholar
  9. 9.
    DANMAP 1999—Consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. Copenhagen, Statens Serum Institut, 2000.Google Scholar
  10. 10.
    DANMAP 2005—Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. Copenhagen, Statens Serum Institut, 2006.Google Scholar
  11. 11.
    Bauraind I, Lopez-Lozano JM, Beyaert A, et al. Association between antibiotic sales and public campaigns for their appropriate use. JAMA 2004;292:2468–70.CrossRefPubMedGoogle Scholar
  12. 12.
    Kleinman A, Eisenberg L, Good B. Culture, illness, and care: Clinical lessons from anthropologic and cross-cultural research. Ann Intern Med 1978;88:251–8.PubMedGoogle Scholar
  13. 13.
    Alberts JF, Sanderman R, Gerstenbluth I, van den Heuvel WJ. Sociocultural variations in help-seeking behavior for everyday symptoms and chronic disorders. Health Policy 1998;44:57–72.CrossRefPubMedGoogle Scholar
  14. 14.
    de Melker RA, Touw-Otten FW, Kuyvenhoven MM. Transcultural differences in illness behaviour and clinical outcome: an underestimated aspect of general practice? Fam Pract 1997;14:472–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Pechere JC, Cenedese C, Muller O, et al. Attitudinal classification of patients receiving antibiotic treatment for mild respiratory tract infections. Int J Antimicrob Agents 2002;20:399–406.CrossRefPubMedGoogle Scholar
  16. 16.
    Deschepper R, Vander Stichele RH, Haaijer-Ruskamp FM. Cross-cultural differences in lay attitudes and utilisation of antibiotics in a Belgian and a Dutch city. Patient Educ Couns 2002;48:161–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Hofstede GH. Culture’s Consequences: Comparing Values, Behaviors, Institutions and Organizations across Nations, ed 2. Thousands Oaks, CA, Sage, 2001.Google Scholar
  18. 18.
    Deschepper R, Vander Stichele RH. Uiteenlopend antibioticagebruik in Europa: de rol van culturele aspecten. Pharm Weekb 2001;136:794–97.Google Scholar
  19. 19.
    Branthwaite A, Pechere JC. Pan-European survey of patients’ attitudes to antibiotics and antibiotic use. J Int Med Res 1996;24:229–38.PubMedGoogle Scholar
  20. 20.
    European Commission. Eurobarometer 55.2. Europeans, Science and Technology. Directorate-General of Research, Brussels, European Commission, 2001.Google Scholar
  21. 21.
    Grol R, Whitfield M, De Maeseneer J, Mokkink H. Attitudes to risk taking in medical decision making among British, Dutch and Belgian general practitioners. Br J Gen Pract 1990;40:134–6.PubMedGoogle Scholar
  22. 22.
    Mangione-Smith R, Elliott MN, Stivers T, McDonald L, Heritage J, McGlynn EA. Racial/ethnic variation in parent expectations for antibiotics: Implications for public health campaigns. Pediatrics 2004;113:e385–94.CrossRefPubMedGoogle Scholar
  23. 23.
    Bauchner H, Pelton SI, Klein JO. Parents, physicians, and antibiotic use. Pediatrics 1999;103:395–401.CrossRefPubMedGoogle Scholar
  24. 24.
    Egger M, Harbarth S, Gervaix A. Differences in antibiotic prescribing patterns between Swiss and US pediatricians. 24th Annual ESPID Meeting, Basel, 2006 (abstract O3).Google Scholar
  25. 25.
    Harbarth S, Albrich W, Pittet D. Semmelweis’ legacy: Insights from an international survey among 265,000 students in 32 countries. Int J Hyg Environ Health 2004;207:481–5.CrossRefPubMedGoogle Scholar
  26. 26.
    Thrane N, Olesen C, Schonheyder HC, Sorensen HT. Socioeconomic factors and prescription of antibiotics in 0- to 2-year-old Danish children. J Antimicrob Chemother 2003;51:683–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Garcia-Rey C, Fenoll A, Aguilar L, Casal J. Effect of social and climatological factors on antimicrobial use and Streptococcus pneumoniae resistance in different provinces in Spain. J Antimicrob Chemother 2004;54:465–71.CrossRefPubMedGoogle Scholar
  28. 28.
    Henricson K, Melander E, Molstad S, et al. Intra-urban variation of antibiotic utilization in children: Influence of socio-economic factors. Eur J Clin Pharmacol 1998;54:653–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Dubois L, Girard M. Breast-feeding, day-care attendance and the frequency of antibiotic treatments from 1.5 to 5 years: A population-based longitudinal study in Canada. Soc Sci Med 2005;60:2035–44.CrossRefPubMedGoogle Scholar
  30. 30.
    Hjern A, Haglund B, Rasmussen F, Rosen M. Socio-economic differences in daycare arrangements and use of medical care and antibiotics in Swedish preschool children. Acta Paediatr 2000;89:1250–6.CrossRefPubMedGoogle Scholar
  31. 31.
    Hjern A, Haglund B, Rosen M. Socioeconomic differences in use of medical care and antibiotics among schoolchildren in Sweden. Eur J Public Health 2001;11:280–3.CrossRefPubMedGoogle Scholar
  32. 32.
    Melander E, Nissen A, Henricson K, et al. Utilisation of antibiotics in young children: Opposite relationships to adult educational levels in Danish and Swedish counties. Eur J Clin Pharmacol 2003;59:331–5.CrossRefPubMedGoogle Scholar
  33. 33.
    Pechere JC. Patients’ interviews and misuse of antibiotics. Clin Infect Dis 2001;33 Suppl 3:S170–3.CrossRefPubMedGoogle Scholar
  34. 34.
    Grigoryan L, Haaijer-Ruskamp FM, Burgerhof JG, et al. Self-medication with antimicrobial drugs in Europe. Emerg Infect Dis 2006;12:452–9.PubMedGoogle Scholar
  35. 35.
    Pechere JC, Hughes D, Kardas P, Cornaglia G. Non-compliance with antibiotic therapy for acute community infections: a global survey. Int J Antimicrob Agents 2007;29(3): 245–53.CrossRefPubMedGoogle Scholar
  36. 36.
    Daley J. Medical uncertainty and practice variation get personal: What should I do about hormone replacement therapy? Ann Intern Med 1999;130:602–4.PubMedGoogle Scholar
  37. 37.
    Bruinsma N, Hutchinson JM, van den Bogaard AE, Giamarellou H, Degener J, Stobberingh EE. Influence of population density on antibiotic resistance. J Antimicrob Chemother 2003;51:385–90.CrossRefPubMedGoogle Scholar
  38. 38.
    Wilson AC, Forsyth JS, Greene SA, Irvine L, Hau C, Howie PW. Relation of infant diet to childhood health: Seven-year follow up of cohort of children in Dundee infant feeding study. BMJ 1998;316:21–5.PubMedGoogle Scholar
  39. 39.
    Harbarth S, Samore MH. Antimicrobial resistance determinants and future control. Emerg Infect Dis 2005;11:794–801.PubMedGoogle Scholar
  40. 40.
    Monnet DL, Ferech M, Frimodt-Moller N, Goossens H. The more antibacterial trade names, the more consumption of antibacterials: A European study. Clin Infect Dis 2005;41:114–7.CrossRefPubMedGoogle Scholar
  41. 41.
    Mousqués J, Renaud T, Scemama O. Variabilité des pratiques médicales en médecine générale: la prescription des antibiotiques dans la rhinopharyngite aiguë. Questions d’Economie de la Santé 2003;70:1–8.Google Scholar
  42. 42.
    Llor C, Bjerrum L. Background for different use of antibiotics in different countries. Clin Infect Dis 2005;40:333.CrossRefPubMedGoogle Scholar
  43. 43.
    Filippini M, Masiero G, Moschetti K. Socioeconomic determinants of regional differences in outpatient antibiotic consumption: Evidence from Switzerland. Health Policy 2005.Google Scholar
  44. 44.
    Matuz M, Benko R, Doro P, et al. Regional variations in community consumption of antibiotics in Hungary, 1996–2003. Br J Clin Pharmacol 2006;61:96–100.CrossRefPubMedGoogle Scholar
  45. 45.
    Harbarth S, Oberlander C. Do health care regulation and physician–industry interaction influence antibiotic resistance rates? The example of antimicrobial prescribing and dispensing in Japan. International Conference on Improved Use of Medicine. Chiang Mai, Thailand, WHO, March 2004 (abstract 391).Google Scholar
  46. 46.
    Park S, Soumerai SB, Adams AS, Finkelstein JA, Jang S, Ross-Degnan D. Antibiotic use following a Korean national policy to prohibit medication dispensing by physicians. Health Policy Plan 2005;20:302–9.CrossRefPubMedGoogle Scholar
  47. 47.
    Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001;357:1851–3.CrossRefPubMedGoogle Scholar
  48. 48.
    European Commission. Eurobarometer 58.2. Antibiotics. European Opinion Research Group. Brussels, Belgium, European Commission, Health and Consumer Protection Directorate-General, 2003.Google Scholar
  49. 49.
    WHO. Death and DALY estimates for 2002 by cause for WHO Member States. WHO, 2002.Google Scholar
  50. 50.
    European Commission. Living conditions in Europe, statistical pocketbook. In: European Commission, Luxembourg, 2000.Google Scholar
  51. 51.
    Danish Government. Structural monitoring—International benchmarking of Denmark. Copenhagen, Danish Government, 2002.Google Scholar
  52. 52.
    U.S. Bureau of Census. International Data Base—Aggregations. Bureau of the Census, 2005.Google Scholar
  53. 53.
    WHO. European health for all database. World Health Organization Regional Office for Europe, 2003.Google Scholar
  54. 54.
    WHO Regional Office for Europe. Highlights on health, 1996–1999. World Health Organization Regional Office for Europe, 2002.Google Scholar
  55. 55.
    Navarro V. Assessment of the World Health Report 2000. Lancet 2000;356:1598–601.CrossRefPubMedGoogle Scholar
  56. 56.
    The social situation in the European Union 2001. Eurostat Luxembourg, 2001.Google Scholar
  57. 57.
    Office for Official Publications of the European Communities. Key data on Health 2000, Data 1985–1995. Edition 1999.Google Scholar
  58. 58.
    Groupement International de la Répartition Pharmaceutique Européenne. European pharmaceutical distribution data 1997. IMS Health, 1998.Google Scholar
  59. 59.
    European Commission. Pharmaceutical prices database. Medicinal products for human use marketed in the European Union In: European Commission, Pharmaceuticals and Cosmetics, ed. Brussels, Belgium, European Commission, 1998.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Stephan Harbarth
    • 1
  • Dominique L. Monnet
    • 2
  1. 1.Infection Control ProgramUniversity Hospitals of GenevaGenevaSwitzerland
  2. 2.National Center for Antimicrobials and Infection ControlStatens Serum InstitutCopenhagenDenmark

Personalised recommendations